Page 138 - 《中国药房》2021年13期

[26] YI H G，CHOI Y J，KANG K S，et al. A 3D-printed local cose control in diabetes[J]. Mater Sci Eng C Mater Biol
drug delivery patch for pancreatic cancer growth suppres- Appl，2020，117：111299.
sion[J]. J Control Release，2016，238：231-241. [38] LONG J，ETXEBERRIA A E，NAND A V，et al. A 3D
[27] WANG Y，SUN L，MEI Z，et al. 3D printed biodegradable printed chitosan-pectin hydrogel wound dressing for lido-
implants as an individualized drug delivery system for caine hydrochloride delivery[J]. Mater Sci Eng C Mater
local chemotherapy of osteosarcoma[J]. Materials & Biol Appl，2019，104：109873.
Design，2020，186：108336. [39] LIANG K，CARMONE S，BRAMBILLA D，et al. 3D
[28] CHUA C，JAIN P，SUSNJAR A，et al. Nanofluidic drug- printing of a wearable personalized oral delivery device：a
eluting seed for sustained intratumoral immunotherapy in first-in-human study[J]. Sci Adv，2018，4（5）：2544.
triple negative breast cancer[J]. J Control Release，2018， [40] GOYANES A，DET-AMORNRAT U，WANG J，et al. 3D
285：23-34. scanning and 3D printing as innovative technologies for
[29] GOYANES A，WANG J，BUANZ A，et al. 3D printing of fabricating personalized topical drug delivery systems[J].
medicines：engineering novel oral devices with unique de- J Control Release，2016，234：41-48.
sign and drug release characteristics[J]. Mol Pharm，2015， [41] 万航，徐恒伟. 3D打印分布式云智能制造绿色生态模式
12（11）：4077-4084. 创新研究[J].科技视界，2020（19）：125-127.
[30] TRENFIELD S J，TAN H X，GOYANES A，et al. Non-de- [42] 林威，皮雪莹，吕洁琼，等. 3D打印技术用于市售华法林
structive dose verification of two drugs within 3D printed 钠片与氢氯噻嗪片的精确分剂量[J].药学学报，2018，53
polyprintlets[J]. Int J Pharm，2020，577：119066. （11）：1901-1907.
[31] GENINA N，BOETKER J P，COLOMBO S，et al. Anti-tu- [43] HOLLÄNDER J，GENINA N，JUKARAINEN H，et al.
berculosis drug combination for controlled oral delivery Three-dimensional printed PCL：based implantable proto-
using 3D printed compartmental dosage forms：from drug types of medical devices for controlled drug delivery[J]. J
product design to in vivo testing[J]. J Control Release， Pharm Sci，2016，105（9）：2665-2676.
2017，268：40-48. [44] AWAD A，TRENFIELD S J，GOYANES A，et al. Resha-
[32] GIOUMOUXOUZIS C I，BAKLAVARIDIS A，KATSAMENIS ping drug development using 3D printing[J]. Drug Discov
O L，et al. A 3D printed bilayer oral solid dosage form Today，2018，23（8）：1547-1555.
combining metformin for prolonged and glimepiride for [45] ZEMA L，MELOCCHI A，MARONI A，et al. Three-di-
immediate drug delivery[J]. Eur J Pharm Sci，2018，120： mensional printing of medicinal products and the chal-
40-52. lenge of personalized therapy[J]. J Pharm Sci，2017，106
[33] SIYAWAMWAYA M，DU TOIT L C，KUMAR P，et al. （7）：1697-1705.
3D printed，controlled release，tritherapeutic tablet matrix [46] TRENFIELD S J，XIAN TAN H，AWAD A，et al. Track-
for advanced anti-HIV-1 drug delivery[J]. Eur J Pharm and-trace：novel anti-counterfeit measures for 3D printed
Biopharm，2019，138：99-110. personalized drug products using smart material inks[J].
[34] KHALED S A，BURLEY J C，ALEXANDER M R，et al. Int J Pharm，2019，567：118443.
3D printing of five-in-one dose combination polypill with [47] ZHENG Z，LV J，YANG W，et al. Preparation and applica-
defined immediate and sustained release profiles[J]. J Con- tion of subdivided tablets using 3D printing for precise
trol Release，2015，217：308-314. hospital dispensing[J]. Eur J Pharm Sci，2020，149：105293.
[35] MARONI A，MELOCCHI A，PARIETTI F，et al. 3D prin- [48] TAGAMI T，ANDO M，NAGATA N，et al. Fabrication of
ted multi-compartment capsular devices for two-pulse oral naftopidil-loaded tablets using a semisolid extrusion-type
drug delivery[J]. J Control Release，2017，268：10-18. 3D printer and the characteristics of the printed hydrogel
[36] PERE C，ECONOMIDOU S N，LALL G，et al. 3D printed and resulting tablets[J]. J Pharm Sci，2019，108（2）：907-
microneedles for insulin skin delivery[J]. Int J Pharm， 913.
2018，544（2）：425-432. （收稿日期：2020-12-04 修回日期：2021-06-06）
[37] WU M，ZHANG Y，HUANG H，et al. Assisted 3D prin- （编辑：孙 冰）
ting of microneedle patches for minimally invasive glu-

·1664 · China Pharmacy 2021 Vol. 32 No. 13 中国药房 2021年第32卷第13期